Compare Davita Inc (DVA) vs General Mills, Inc. (GIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs General Mills, Inc. — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while General Mills, Inc. trades at $32.61 (market cap $16.99B). The key difference: General Mills, Inc. is the larger of the two by market cap, and General Mills, Inc. pays a 7.68% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and General Mills, Inc. for 106 Days on average.
| DVA | GIS | |
|---|---|---|
Market Cap | $11.28B | $16.99B |
Volume | 650,294 | 10,265,203 |
Sector | Health | Consumer Staples |
52-Week High | $240.96 | $49.36 |
52-Week Low | $103.87 | $31.67 |
Typical Hold Time | 113 Days | 106 Days |
Enterprise Value | $24.00B | $30.17B |
Dividend Yield | — | 7.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
General Mills (GIS) trades at $32.59, up 1.27% on the day, showing mixed technical signals with bearish moving averages but oversold RSI readings. The company faces fundamental challenges with negative net income margin (-4.89%) and ROE (-10.55%) for 2026, though it maintains strong operating cash flow of $2.92B. Recent CEO transition to Dana McNabb and a $3B cost-saving initiative aim to drive turnaround efforts amid declining revenue trends.
The stock presents a value opportunity with low P/E (9.23) and P/S (0.93) ratios, supported by a consistent dividend yield. However, execution risks remain high given margin pressures and competitive headwinds. Analyst consensus is cautious with 61% hold ratings, though the $36 price target suggests 10% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →
